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per cent in these areas (O’Brien and others 2006). In western 
Spain, there was a steady increase in the prevalence of M bovis 
infection in free-ranging Iberian red deer (Cervus elaphus his-
panicus) between 1997 and 2002, reaching 1·7 per cent (Parra 
and others 2006). M bovis has also been detected in captive 
herds of deer in the USA, Canada, New Zealand, Europe and 
Asia. In the USA, the spread of bovine TB in captive herds is 
strongly associated with inter-herd and cross-country move-
ments of infected deer (Essey and Koller 1994). M bovis was 
diagnosed in 41 captive herds of deer in the USA between 1991 
and 2003 (Massengill 2005), in 35 captive herds in Canada 
between 1989 and 1998 (Essey and Koller 1994, Massengill 
2004) and in 41 of 14,842 farmed deer slaughtered in Ireland 
between 1993 and 1996 (Quigley and others 1997). TB has 
also been diagnosed in captive axis deer (Cervus axis) in India 
(Baska and others 1975), in elk (Cervus elaphus nelsoni) in 
Korea (Kim and others 2002) and sika deer in Japan (Itoh and 
others 1992) and China (Shilang and Shanzhi 1985).
As a result of a series of confirmed cases in the mid 1980s, 
TB was designated a ‘notifiable’ disease in farmed deer in Great 
Britain (R. de la Rua, personal communication). Similarly, a 
1991 outbreak in captive elk, attributed to the importation of 
an infected elk, encouraged the government and industry lead-
ers in the USA to draft a Uniform Methods and Rules for the 
Eradication of bovine TB in captive cervids (Essey and Koller 
1994). In conjunction with the Deer Farmers’ Association 
and the Deer Branch of the New Zealand Veterinary Medical 
Association, the New Zealand Ministry of Agriculture and 
Fisheries adopted a voluntary TB control scheme in 1984 fol-
lowed by a compulsory national TB control scheme in 1991 
(de Lisle and others 2001). Such TB control campaigns have 
generally relied on test and removal, slaughterhouse surveil-
lance, movement restrictions and/or wildlife reservoir con-
trol strategies. In the UK, USA and Canada, farmed deer are 
monitored by a combination of slaughter surveillance and 
skin-testing strategies. In the USA the programme is volun-
tary, but required for interstate transport and herd accredita-
tion. In Canada, a negative TB test for each deer is required for 
a change of ownership or any movement, except to slaughter. 
In New Zealand, captive deer more than six months of age are 
monitored regularly by skin testing (approximately 700,000 
were tested in 2004) and all deer are inspected for lesions 
FARMED deer constitute a significant alternative livestock 
industry, with numbers exceeding two million in New 
Zealand, one million in China, 500,000 in the USA, 400,000 in 
Russia and 100,000 in Canada (Griffin and Mackintosh 2000). 
They are exposed to other livestock and to free-ranging wild-
life and are moved between herds and across borders, and 
there is therefore a risk that infectious diseases may spread 
among and between farmed deer, traditional livestock and 
free-ranging wildlife. In addition, many deer are kept in parks 
reserves and private estates for hunting, zoological, and aes-
thetic purposes, and their intensive management promotes 
the spread of infectious diseases among them.
The causal agent of bovine tuberculosis (TB) is 
Mycobacterium bovis. This zoonotic pathogen has a wide host 
range and is the species of Mycobacterium species most often 
isolated from tuberculous cattle and captive deer. There are 
several wildlife maintenance hosts of bovine TB, including the 
Eurasian badger (Meles meles), brushtail possum (Trichosurus 
vulpecula), white-tailed deer (Odocoileus virginianus), bison 
(Bison bison), lechwe antelope (Kobus leche) and African 
buffalo (Syncerus caffer) (de Lisle and others 2001). In addi-
tion to white-tailed deer, M bovis has been isolated from red 
deer (Cervus elaphus), sika deer (Cervus nippon), roe deer 
(Capreolus capreolus), fallow deer (Dama dama), muntjac 
deer (Muntiacus reevesi), mule deer (Odocoileus hemionus), 
and several other deer species (Griffin and Mackintosh 2000, 
Delahay and others 2001, 2006). Free-ranging and cap-
tive deer are implicated in the spread of M bovis to cattle in 
the USA, Canada and New Zealand (Essey and Koller 1994, 
de Lisle and others 2001, O’Brien and others 2006) and to 
human beings (Fanning and Edwards 1991, Whiting and 
Tessaro 1994, Wilkins and others 2003, Bucholz 2005). The 
prevalence of TB in free-ranging deer populations in south-
west England has been estimated to range from 1 per cent for 
roe and red deer to 4·4 per cent for fallow deer and 5·2 per 
cent for muntjac deer. A recent assessment determined that 
free-ranging deer in the UK are a potential source of infection 
to cattle in localised areas (Delahay and others 2006).
In the USA, the prevalence of TB in free-ranging white-tailed 
deer in certain areas of Michigan reached 5 per cent in the late 
1990s, but increased hunting and limitations on wide-scale 
feeding practices have decreased this rate to approximately 1 
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Blood culture and stimulation conditions for 
the diagnosis of tuberculosis in cervids by the 
Cervigam assay
W. R. Waters, M. V. Palmer, T. C. Thacker, K. Orloski, P. Nol, N. P. Harrington,
S. C. Olsen, B. J. Nonnecke
Mitogen- and antigen-induced interferon-γ (IFN-γ) responses of peripheral blood leucocytes from cervids 
were evaluated by a commercial whole-blood assay. The assay was applied to Mycobacterium bovis-infected 
white-tailed deer and reindeer, M bovis BCG-vaccinated white-tailed deer and elk, and unvaccinated, 
uninfected white-tailed deer, fallow deer, elk and reindeer. The responses of the M bovis-infected 
white-tailed deer to pokeweed mitogen (PWM) varied with time and between individuals. The responses 
of the M bovis-infected reindeer to PWM and M bovis purified protein derivative (PPD) were positively 
associated. Samples from tuberculosis-free captive herds in various parts of the USA were also evaluated. 
Four per cent of fallow deer, 20 per cent of elk, 44 per cent of white-tailed deer, and 91 per cent of reindeer 
had responses to PWM exceeding 0·25 Δ optical density, that is, PWM stimulation minus no stimulation. The 
specificity of the responses to M bovis PPD and a Mycobacterium tuberculosis complex-specific antigen 
rESAT-6:CFP-10, excluding animals not responding to PWM, ranged from 78 per cent to 100 per cent and was 
dependent upon the species and the positive response cut-off value. The results show that the commercial 
assay is valid for the detection of TB in reindeer; however, further development of the assay will be required 
before it is used in surveillance programmes for white-tailed deer, fallow deer, and elk.
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at slaughter (approximately 600,000 were tested in 2004). In 
contrast with New Zealand, compliance with TB control strat-
egies in many other countries is poor. In 2003, less than 6 per 
cent of approximately 500,000 captive deer in the USA were 
tested for TB and less than 1 per cent of 363 captive herds in 
the UK submitted to voluntary testing. The reasons for such 
poor compliance include inadequate handling facilities, inju-
ries resulting from the handling required, the poor percep-
tion by owners of the specificity of skin testing in cervids, and 
in the USA, the reduction in interstate movements due to the 
restrictions imposed as a result of chronic wasting disease. 
Estimates of the sensitivity and specificity of skin tests for 
naturally infected red deer, fallow deer and white-tailed deer 
vary according to the study and species, with ranges from 80 
to 84 per cent for sensitivity and 46 to 86 per cent for specifi-
city (Palmer and others 2001); no estimates are available for 
naturally infected reindeer (Rangifer tarandus).
A blood-based TB test for initial surveillance might 
increase the compliance of deer farmers. Ancillary blood-
based tests currently used in TB control programmes around 
the world include the fluorescence polarisation assay, ELISA 
and lateral flow antibody-based tests, in addition to assays 
based on interferon-γ (IFN-γ), for example, the Cervigam 
assay (Prionics) and lymphocyte blastogenesis. Their use var-
ies between countries and they are not widely utilised with 
cervids. The Cervigam assay is particularly attractive owing 
to the widespread acceptance of other assays based on IFN-γ, 
for example, Bovigam (Prionics) for cattle and Quantiferon 
Gold (Cellestis) for human beings.
The aim of this study was to evaluate the Cervigam assay 
for TB surveillance by applying it to samples from four species 
of captive cervid of significance to the national programme 
in the USA. Its objectives were to evaluate a positive standard 
as an indicator of the performance of the assay and to deter-
mine its specificity with samples from TB-free herds. Antigens 
used for the specificity studies include M bovis purified pro-
tein derivative (PPD), a complex antigen mixture and a fusion 
of recombinant Early Secreted Antigenic Target-6 kDa pro-
tein and Culture Filtrate Protein 10 (rESAT-6-CFP-10), generally 
a Mycobacterium tuberculosis-complex-specific antigen. Both 
antigens are commonly used in TB tests based on IFN-γ.
MATERIALS AND METHODS
Animals, M bovis infection, and 
M bovis BCG vaccination
Eleven yearling white-tailed deer were given 300 colony 
forming units (cfu) M bovis strain 95-1315 by intratonsillar 
instillation as described by Thacker and others (2006) and 
Palmer and others (2006), and 13 reindeer were given 1 x 
105 cfu of the same strain by the same route. Blood was col-
lected monthly during the six months after the challenge for 
evaluation of responses to mitogen and antigen. Infection 
was confirmed postmortem in each animal by pathological 
examination and bacteriological culture of tissues (Palmer 
and others 2006, Thacker and others 2006). All the inoculated 
reindeer were classified as reactors to a comparative cervi-
cal skin test at 90 and 240 days after inoculation (Palmer 
and others 2006); the white-tailed deer were not skin tested. 
Despite the different doses administered the distribution and 
severity of the lesions were similar in the white-tailed deer 
and reindeer.
Eight yearling white-tailed deer and four elk were vac-
cinated subcutaneously with 5 x 107 cfu M bovis BCG Pasteur 
as described by Waters and others (2002, 2004). Blood was 
collected six weeks after the vaccination to evaluate the effects 
of delays in setting up the assay (to mimic overnight delivery) 
on the IFN-γ responses. All the vaccinated white-tailed deer 
were classified as reactors to a comparative cervical skin test 
four-and-a-half months after they were vaccinated, and all 
the elk reacted similarly after eight months.
For the specificity studies, that is the response of unin-
fected deer to M bovis antigens, samples were collected 
from TB-monitored herds with no history of TB. Samples 
were obtained from fallow deer in Iowa, North Carolina 
and Texas, from elk in Iowa, Minnesota, North Carolina, 
Wisconsin and Ontario Canada, from white-tailed deer in 
Iowa and Wisconsin, and from reindeer in Alaska, Colorado, 
Iowa, Michigan, Nebraska, Ohio, North Dakota, Oregon, 
Pennsylvania, Tennessee and Wisconsin. The samples from 
Iowa were processed immediately and those from the other 
states within 24 hours of collection.
Whole blood cultures and analysis 
of IFN-γ production
Heparinised blood was dispensed in 1·5 ml aliquots into 
individual wells of a 24-well plate (Falcon 353047; Becton 
Dickinson). Treatments included no stimulation (phos-
phate-buffered saline [PBS] only), and stimulation with 20 
µg/ml Mycobacterium avium PPD (PPDa) (Prionics), 20 µg/ml 
M bovis PPD (PPDb) (Prionics), 10 µg/ml rESAT-6:CFP-10, or 
mitogen (Table 1) in PBS as described by Palmer and oth-
ers (2004) and Waters and others (2006). Several mitogens, 
including phytohaemagglutinin, concanavalin-A and poke 
weed mitogen (PWM) were evaluated for use as polyclonal 
stimulators of IFN-γ secretion by blood leucocytes from elk 
and reindeer (Table 1). The mitogens were not titrated for 
the samples from fallow deer owing to the limited volume of 
blood available for testing.
As a result of this comparison, PWM at 20 µg/ml was 
selected for use in subsequent studies. Diagnostic laborato-
ries in the USA generally consider a PWM response of either 
0·1 or 0·25 Δ OD as indicative of a positive IFN-γ response, 
that is, with Bovigam and with a limited number of samples 
for Cervigam.
In addition to the standard assay procedure, blood tubes 
were held for eight or 24 hours before culture to determine 
TABLE 1: Titration of mitogens for the selection of a positive control stimulant in three elk 
and 18 reindeer
Mitogen Concentrations (µg/ml)
Mean (se) optical density
Elk Reindeer
Pokeweed mitogen 20 0·288 (0·02)* 1·087 (0·18)*
10 0·275 (0·02)* 1·041 (0·17)*
 5 0·160 (0·05) 0·954 (0·15)*
Concanavalin A 20 0·103 (0·05) 0·090 (0·01)
10 0·057 0·098 (0·01)
5 0·073 0·097 (0·01)
Phytohaemagglutin 20 0·085 (0·01) 0·152 (0·03)*
10 0·136 (0·03) 0·226 (0·05)*
 5 0·171 (0·05) 0·585 (0·16)*
 1 ND 0·137 (0·01)*
Phosphate-buffered saline NA 0·059 0·081 (0·01)
* Significantly different from phosphate-buffered saline (P<0·05)
NA Not applicable, ND Not determined
TABLE 2: Relative specificity of the Cervigam assay for animals with positive responses to 
pokeweed mitogen (PWM)
PPDb–PPDa and PPDb–PBS rESAT-6:CFP-10–PBS
Species* Number <0·1 (%) <0·05 (%) <0·1 (%) <0·05 (%)
Elk  51 90 78 100 96
White-tailed deer  95 98 92  97 95
Reindeer 106 91 83  94 87·5
* Animals were from TB-monitored herds without any previous history of TB
PPDa Mycobacterium avium purified protein derivative, PPDb Mycobacterium bovis purified protein 
derivative
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the effects of delays on the response. The blood cultures were 
incubated for 48 hours, and plasma was separated by centrifug-
ation and stored at –80°C. The concentrations of IFN-γ in 
plasma were determined with an ELISA-based kit (Cervigam; 
Prionics). The absorbance of the standards and test sam-
ples was read at 450 nm on an ELISA place reader (Molecular 
Devices). Individual samples were analysed in duplicate and 
the assay was repeated if the duplicate responses were not 
consistent. The concentrations of IFN-γ (ng/ml) in the test 
samples were determined by comparing the absorbance of 
the test samples with the absorbance of the standards within 
the linear response of the assay. The data are also presented 
as optical density (OD) readings or as differences between the 
response to antigen or mitogen and the response to PBS (Δ OD 
or Δ IFN-γ [ng/ml]).
The interpretation of the responses to antigen was based 
on methods commonly used in the USA for the Bovigam assay, 
and a limited number of tests with the Cervigam assay. With 
this method, the responses to PPDb must exceed the responses 
to both PPDa and PBS by a given cut-off (0·1 or 0·05 Δ OD) to 
be considered positive. The responses to the specific antigen 
(rESAT-6:CFP-10) were compared with the respective responses 
to PBS. The data are presented as the percentage of animals 
with responses to PPDb or rESAT-6:CFP-10 up to 0·1 or 0·5 Δ OD 
(Table 2).
Statistical analysis
The data were analysed by a one-way analysis of variance fol-
lowed by a Tukey-Kramer multiple comparisons test, using 
a commercially available statistics programme (InStat 2.00; 
GraphPAD Software). Pearson’s product-moment correlations 
were computed between the IFN-γ concentrations in plasma 
stimulated with pokeweed mitogen or PPDb.
RESULTS
The magnitude of the responses to PWM was dependent 
upon the species of deer (Table 3). Ninety-one per cent of 
the reindeer had responses to PWM exceeding 0·25 Δ OD, 
whereas less than 44 per cent of the other deer species had 
responses to PWM exceeding 0·25 Δ OD. The response by fal-
low deer was particularly poor with less than 5 per cent hav-
ing a response to PWM exceeding 0·25 Δ OD. The percentages 
of PWM responses exceeding 0·1 Δ OD were 22 per cent, 46 
per cent, 56 per cent and 98 per cent for the fallow deer, elk, 
white-tailed deer and reindeer, respectively. The mean PWM 
responses by the white-tailed deer and reindeer from the TB-
monitored herds were similar to those observed by Palmer 
and others (2004) and Waters and others (2006) in M bovis-
infected and control deer.
 The OD readings were standardised to units of ng/ml for 
longitudinal studies. The responses of the M bovis-infected 
white-tailed deer to PWM varied widely between individual 
deer and over time (Fig 1). Some deer had PWM responses 
that never exceeded 10 ng/ml (equivalent to approximately 
0·2 Δ OD) (Fig 1a) and were categorised as low responders, 
but other deer had responses that exceeded 30 ng/ml (equiva-
lent to approximately 0·4 Δ OD) (Fig 1c) and were categorised 
as high responders. Over time, the responses of individual 
deer to PWM ranged from 0 to 30 ng/ml. Similar variations 
in the responses of uninfected white-tailed deer to PWM were 
detected (data not shown).
The responses of the M bovis-infected reindeer and 
white-tailed deer to PWM and PPDb were positively corre-
lated (P<0·0001) (Fig 2). However, the responses of the 
white-tailed deer were not as large, with numerous samples 
in the minimal response range, as indicated by the cluster 
in the lower left corner of Fig 2a. Thirty-five per cent of the 
infected white-tailed deer did not have responses to both 
PWM and M bovis PPD exceeding 0·25 Δ OD, indicated by the 
shaded box in Fig 2a.
Under field conditions, samples are routinely shipped 
overnight, so that there is a delay before they are analysed. 
However, delays of eight or 24 hours did not significantly 
affect the response to PWM or PPDb of white-tailed deer or 
elk vaccinated with M bovis BCG (Fig 3), in agreement with 
the results of studies with reindeer (Waters and others 2006). 
However, shipping by overnight courier may result in tem-
perature fluctuations, excessive vibrations and atmospheric 
pressure changes. Also, caution is needed in the interpreta-
tion of these findings owing to limitations in the stimulation 
by PWM of samples from elk and white-tailed deer, and their 
modest response to vaccination. For white-tailed deer, fal-
low deer and reindeer, the ability to respond to PWM was not 
affected by overnight transport because the responses of sam-
ples processed immediately were comparable to those proc-
essed after being transported for approximately 24 hours. In 
contrast, 86 of the 104 samples from elk (83 per cent) that 
were shipped overnight failed to respond to PWM, compared 
with 12 of 19 (63 per cent) of those that were processed 
immediately.
Samples were obtained from TB-free herds across the USA 
and from Canada to evaluate the specificity of the test rela-
tive to PPDb and rESAT-6:CFP-10. Animals with PWM responses 
less than 0·25 Δ OD were excluded, as well as all the fallow 
deer because only 4·2 per cent of them had PWM responses 
exceeding 0·25 Δ OD. Table 3 shows that 20·3 per cent of elk, 
43·9 per cent of white-tailed deer and 91·4 per cent of rein-
deer had responses to PWM exceeding 0·25 Δ OD. The inter-
TABLE 3: Differences between the interferon-γ responses of blood samples from various 
cervids stimulated with pokeweed mitogen or not stimulated (that is, phosphate-buffered 
saline), expressed as the differences in optical density (OD) determined by ELISA
Species* Number Mean (se) Median (range) Δ OD >0·25 (%)
Fallow deer 213 0·085 (0·02) 0·035 (0–3·637) 4·2
Elk 123 0·174 (0·02) 0·096 (0–1·354) 20·3
White-tailed deer 171 0·426 (0·05) 0·168 (0–2·862) 43·9
Reindeer 116 1·517 (0·08) 1·391 (0·120-3·260) 91·4
* Animals were from TB-monitored herds without any previous history of TB
FIG 1: Variations in the capacity of blood 
leucocytes from 11 Mycobacterium 
bovis-infected white-tailed deer to 
respond to pokeweed mitogen (PWM). 
Blood was collected into heparinised 
tubes from infected deer at regular 
intervals and stimulated with 20 
µg/ml PWM or phosphate-buffered 
saline. After 48 hours incubation at 
37°C in 5 per cent carbon dioxide in 
air, interferon-γ (IFN-γ) concentrations 
in plasma were determined by the 
Cervigam assay (Prionics). The deer 
could be divided into (a) low, (b) moderate and (c) high responders in terms of the 
difference between PWM-stimulated and non-stimulated cultures (Δ ng/ml). The numbers 
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pretation of the responses to antigen was based on methods 
commonly used in the USA for the Bovigam assay, and the 
results of a limited number of tests with the Cervigam assay. 
With this method, the responses to PPDb must exceed the 
responses to both PPDa and PBS by a given amount, that is 
0·1 or 0·05 Δ OD, to be considered positive. The responses 
to the specific antigen rESAT-6:CFP-10 were compared to the 
responses to PPDb and no stimulation, that is PBS. Specificities 
ranged from 78 to 100 per cent depending upon the species 
of deer, the antigen, and the cut-off value (Table 2). In gen-
eral, slightly higher specificities were obtained with rESAT-6:
CFP-10 than with PPDb.
DISCUSSION
The initial development of IFN-γ-based tests for TB surveillance 
requires a consistent stimulant to demonstrate the functional 
capacity of the sample, a determination of specificity with a 
reasonable number of viable samples from uninfected ani-
mals, and the ability to detect responses to specific antigens 
by tuberculous animals. Prior studies have demonstrated the 
potential for IFN-γ-based tests to detect tuberculous white-
tailed deer, elk and reindeer (Slobbe and others 2000, Palmer 
and others 2004, Harrington and others 2006, Waters and 
others 2006). For reindeer, these findings were extended: PWM 
was identified as a reliable indicator of IFN-γ protein produc-
tion, few samples were excluded owing to their inability to 
produce IFN-γ in response to the positive control stimulant, 
and the specificity of the assay was determined to be from 
approximately 83 to 94 per cent depending upon the anti-
gen and the cut-off value applied. The specificity of the assay 
was at least comparable to the best estimates for the range of 
specificities of skin testing of other cervid species, that is, 46 
to 86 per cent (Palmer and others 2001). An estimate for the 
specificity of skin testing in reindeer is not available, but there 
are anecdotal reports of many false positive reactions. These 
findings show that the Cervigam assay is potentially useful 
for the surveillance.
In contrast, the findings show that the Cervigam assay in 
its present form is of limited usefulness with samples from 
white-tailed deer, elk and fallow deer. A major concern was 
the poor response to mitogen stimulation by more than 50 
per cent of the samples from each of these species. With 
M bovis-infected white-tailed deer, a poor response to PWM 
indicated a concurrent poor response to mycobacterial anti-
gen. Only two of 63 samples from infected white-tailed deer 
had a response to PWM of less than 0·25 Δ OD and a concur-
rent response to M bovis PPD of more than 0·05 Δ OD, the low-
est recommended cut-off for a positive response. Only 60 per 
cent of the samples from M bovis-infected white-tailed deer 
showed a response to PWM exceeding 0·25 Δ OD and these 
responses varied widely with time and between individual 
deer. These findings indicate either that the sample leucocytes 
were unable to produce IFN-γ consistently, or that the assay 
was unable to detect the cytokine consistently.
The failure of the tests my be related to the biology of the 
host’s response, the interpretation of the assay, the failure of 
the assay, and/or the poor quality of the sample. Captive deer 
are particularly prone to acute stress when handled, which 
may result in sudden increases in the plasma concentration of 
cortisol and/or other cytokine response inhibitors (Rehbinder 
and others 1982, Kock and others 1987). High levels of cor-
tisol may result in reductions in IFN-γ due to the inhibition 
of transcription factor NF-κB. The mechanisms of the regula-
tion of IFN-γ gene expression, including positive and negative 
feedback loops of production, are virtually unknown for deer. 
Translation of the human IFN-γ gene is inhibited by the acti-
vation of a RNA-dependent protein kinase via a pseudoknot 
sensor on the 5´-untranslated region of IFN-γ mRNA, and the 
subsequent phosphorylation of eukaryotic initiation factor-
2α (Kaempfer 2003). Furthermore, T cell activation may be 
inadequate owing to the presence of inhibitory cytokines, 
other inhibitory factors, or a lack of co-stimulation. Another 
reason for the inconsistent detection of IFN-γ in the assay 
may be the degradation of synthesised IFN-γ as a result of the 
activation of proteases or inhibitors of glycoprotein-process-
ing enzymes (Kosuge and Toyoshima 2000). Alternatively, 
changes in the glycosylation of IFN-γ may decrease its half-
life. The inhibition of the extracellular release of synthesised 
IFN-γ, or the upregulation of IFN-γ receptors with immedi-
ate binding of synthesised IFN-γ, or the masking of IFN-γ by 
other factors, could also reduce the availability of free IFN-γ 
in stimulated plasma.
The mitogens commonly used as positive control stimu-
lants may not consistently induce acceptable quantities of 
IFN-γ in samples from captive deer, and the interpretation 
of the assay is difficult without a consistent positive control 
stimulus. The results of this study emphasise the need for an 
adequate cut-off value for the assurance of quality control. A 
minimal cut-off value of 0·1 Δ OD, as used in some labora-
tories in the USA, is probably insufficient to assure the test’s 
validity. The unsuccessful stimulation with mitogens may 
indicate either that there are different mechanisms of activa-
tion in cervids, or that there are inhibiting factors in cervid 
blood. The antibodies used for the Cervigam assay may not 
recognise IFN-γ from different deer species (as indicated with 
fallow deer) and polymorphisms in antigen-binding sites 
may result in variability in detection between individual ani-
mals (as indicated with white-tailed deer). Delays in setting 
up the assay did not significantly affect the response (Fig 3), 
but samples from deer may be subject to interference result-
ing from temperature fluctuations and other transport-asso-
ciated events, such as excessive vibrations and shaking. In the 
elk, a higher proportion of the samples that were shipped 
overnight failed to respond to PWM than of the samples that 
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FIG 2: Correlations 
between the responses 
to pokeweed 
mitogen (PWM) and 
Mycobacterium 
bovis purified protein 
derivative (PPDb) of (a) 
white-tailed deer and 
(b) reindeer, at intervals 
after their intratonsillar 
inoculation with M 
bovis. Heparinised 
blood was stimulated 
with 20 µg/ml PWM 
and M bovis PPD. After 
48 hours incubation 
at 37°C in 5 per cent 
carbon dioxide in air, 
interferon-γ 
(IFN-γ) concentrations 
in plasma were 
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cause interference beyond any caused by delays in setting up 
the assay. For the further development of the test it may be 
necessary to evaluate additional positive control stimulants, 
for example, ionomycin, phorbol-12-myristate 13-acetate 
and recombinant interleukin-2, or cocktails of positive con-
trol stimulants, to establish IFN-γ protein sequences from dif-
ferent species of deer (at present only the sequence for red 
deer has been published) (Sweeney and others 2001), and 
investigate different combinations of antibodies for the sand-
wich ELISA (Buchan and Griffin 1990), and/or enhanced sam-
ple delivery/stimulation procedures.
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